MedPath
FDA Approval

escitalopram

FDA-approved pharmaceutical product with comprehensive regulatory information, manufacturing details, and complete labeling documentation.

FDA Approval Summary

Effective Date
May 31, 2023
Labeling Type
HUMAN PRESCRIPTION DRUG LABEL
Escitalopram(20 mg in 1 1)

Registrants1

Companies and organizations registered with the FDA for this drug approval, including their contact information and regulatory details.

Manufacturing Establishments1

FDA-registered manufacturing facilities and establishments involved in the production, packaging, or distribution of this drug product.

Graviti Pharmaceuticals Private Limited

Graviti Pharmaceuticals Private Limited

Graviti Pharmaceuticals Private Limited

650884781

Products3

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

escitalopram

Product Details

NDC Product Code
69844-079
Application Number
ANDA078777
Marketing Category
ANDA (C73584)
Route of Administration
ORAL
Effective Date
May 31, 2023
Code: 5U85DBW7LOClass: ACTIMQuantity: 20 mg in 1 1
BUTYLATED HYDROXYANISOLEInactive
Code: REK4960K2UClass: IACT
CROSCARMELLOSE SODIUMInactive
Code: M28OL1HH48Class: IACT
HYPROMELLOSESInactive
Code: 3NXW29V3WOClass: IACT
CELLULOSE, MICROCRYSTALLINEInactive
Code: OP1R32D61UClass: IACT
LACTOSE MONOHYDRATEInactive
Code: EWQ57Q8I5XClass: IACT
HYDROXYPROPYL CELLULOSE (1600000 WAMW)Inactive
Code: RFW2ET671PClass: IACT
POLYETHYLENE GLYCOL, UNSPECIFIEDInactive
Code: 3WJQ0SDW1AClass: IACT
TITANIUM DIOXIDEInactive
Code: 15FIX9V2JPClass: IACT
MAGNESIUM STEARATEInactive
Code: 70097M6I30Class: IACT

escitalopram

Product Details

NDC Product Code
69844-078
Application Number
ANDA078777
Marketing Category
ANDA (C73584)
Route of Administration
ORAL
Effective Date
May 31, 2023
BUTYLATED HYDROXYANISOLEInactive
Code: REK4960K2UClass: IACT
Code: 5U85DBW7LOClass: ACTIMQuantity: 10 mg in 1 1
CELLULOSE, MICROCRYSTALLINEInactive
Code: OP1R32D61UClass: IACT
HYDROXYPROPYL CELLULOSE (1600000 WAMW)Inactive
Code: RFW2ET671PClass: IACT
CROSCARMELLOSE SODIUMInactive
Code: M28OL1HH48Class: IACT
HYPROMELLOSESInactive
Code: 3NXW29V3WOClass: IACT
LACTOSE MONOHYDRATEInactive
Code: EWQ57Q8I5XClass: IACT
MAGNESIUM STEARATEInactive
Code: 70097M6I30Class: IACT
POLYETHYLENE GLYCOL, UNSPECIFIEDInactive
Code: 3WJQ0SDW1AClass: IACT
TITANIUM DIOXIDEInactive
Code: 15FIX9V2JPClass: IACT

escitalopram

Product Details

NDC Product Code
69844-077
Application Number
ANDA078777
Marketing Category
ANDA (C73584)
Route of Administration
ORAL
Effective Date
May 31, 2023
BUTYLATED HYDROXYANISOLEInactive
Code: REK4960K2UClass: IACT
Code: 5U85DBW7LOClass: ACTIMQuantity: 5 mg in 1 1
HYDROXYPROPYL CELLULOSE (1600000 WAMW)Inactive
Code: RFW2ET671PClass: IACT
LACTOSE MONOHYDRATEInactive
Code: EWQ57Q8I5XClass: IACT
HYPROMELLOSESInactive
Code: 3NXW29V3WOClass: IACT
POLYETHYLENE GLYCOL, UNSPECIFIEDInactive
Code: 3WJQ0SDW1AClass: IACT
MAGNESIUM STEARATEInactive
Code: 70097M6I30Class: IACT
CELLULOSE, MICROCRYSTALLINEInactive
Code: OP1R32D61UClass: IACT
CROSCARMELLOSE SODIUMInactive
Code: M28OL1HH48Class: IACT
TITANIUM DIOXIDEInactive
Code: 15FIX9V2JPClass: IACT
© Copyright 2025. All Rights Reserved by MedPath